119 related articles for article (PubMed ID: 2008785)
41. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884
[No Abstract] [Full Text] [Related]
42. [Rational therapy with G-CSF and GM-CSF].
Link H; Herrmann F; Welte K; Aulitzky WE; Ganser A; Kern WV; Meyer P; Schrappe M; Schmoll HJ; Werdan K
Med Klin (Munich); 1994 Aug; 89(8):429-41. PubMed ID: 7526144
[No Abstract] [Full Text] [Related]
43. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
Fernández-Varón E; Villamayor L
Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
[TBL] [Abstract][Full Text] [Related]
44. Serum cytokine levels in patients with neutropenia.
Greendyke RM; Sharma K; Gifford FR
Arch Pathol Lab Med; 1994 Dec; 118(12):1193-5. PubMed ID: 7526820
[TBL] [Abstract][Full Text] [Related]
45. [Cyclic neutropenia and treatment with granulocyte colony-stimulating factor (G-CSF)].
Anninga JK; Weening RS
Ned Tijdschr Geneeskd; 1995 Feb; 139(8):394-7. PubMed ID: 7885503
[TBL] [Abstract][Full Text] [Related]
46. Colony-stimulating factors stimulate some treatments, continue to evolve.
Volkers N
J Natl Cancer Inst; 1999 Feb; 91(3):210-2. PubMed ID: 10037097
[No Abstract] [Full Text] [Related]
47. Disappointments in treating acute leukemia in the elderly.
Hamblin TJ
N Engl J Med; 1995 Jun; 332(25):1712-3. PubMed ID: 7539110
[No Abstract] [Full Text] [Related]
48. [Current methods in the treatment of iatrogenic neutropenia].
Meriggi F; Zaniboni A
Tumori; 2003; 89(6):12-20. PubMed ID: 14870835
[No Abstract] [Full Text] [Related]
49. Short communication: prolonged severe neutropenia after chlorambucil therapy and prompt reversal with GM-CSF.
Majumdar G; Phillips JK; Pearson TC
Leuk Lymphoma; 1994 Oct; 15(3-4):361-2. PubMed ID: 7866288
[No Abstract] [Full Text] [Related]
50. Mood disorder with manic features in a patient treated with granulocyte-monocyte colony stimulating factor.
Zdanowicz NH; Reynaert CM; Janne PP; Wulleman PJ; Chatelain CJ
Psychosomatics; 1996; 37(3):305-6. PubMed ID: 8849508
[No Abstract] [Full Text] [Related]
51. [Macrophage-colony stimulating factor (M-CSF) and its use in clinical practice].
Groblewska M; Mroczko B; Szmitkowski M
Pol Arch Med Wewn; 2004 Mar; 111(3):355-65. PubMed ID: 15230219
[No Abstract] [Full Text] [Related]
52. Colony-stimulating factor use in the context of refined risk and benefit assessments.
Crawford J
Oncology (Williston Park); 2006 Apr; 20(5 Suppl 4):9-10. PubMed ID: 16736982
[No Abstract] [Full Text] [Related]
53. Misleading title and abstract in recent granulocyte-macrophage colony-stimulating factor trial.
Grossman JS; Kroener J
J Clin Oncol; 1999 May; 17(5):1644-5. PubMed ID: 10334557
[No Abstract] [Full Text] [Related]
54. Granulocyte-macrophage colony-stimulating factor for the treatment of neutropenia associated with large granular lymphocytic leukemia.
Folk SM; Tefferi A
Am J Hematol; 1992 Apr; 39(4):316. PubMed ID: 1553964
[No Abstract] [Full Text] [Related]
55. ESMO recommendations for the application of haematopoietic growth factors (hGFs).
Ann Oncol; 2001 Sep; 12(9):1219-20. PubMed ID: 11697831
[No Abstract] [Full Text] [Related]
56. Granulocyte-macrophage colony-stimulating factor (GM-CSF): a variety of possible applications in clinical medicine.
Weiss M; Belohradsky BH
Infection; 1992; 20 Suppl 2():S81-3. PubMed ID: 1493939
[No Abstract] [Full Text] [Related]
57. Colony-stimulating factors after the treatment of pediatric malignant diseases.
Schuler D
Pediatr Hematol Oncol; 1997; 14(1):iii-v. PubMed ID: 9021806
[No Abstract] [Full Text] [Related]
58. Hematopoietic growth factors in rheumatoid arthritis: a critical approach to their use in view of possible adverse effects.
Vreugdenhil G; Schattenberg A; Dompeling EC; Swaak AJ; De Witte T
Am J Med; 1993 Feb; 94(2):229-31. PubMed ID: 7679247
[No Abstract] [Full Text] [Related]
59. Granulocyte-macrophage colony-stimulating factor treatment of neutropenia associated with Felty's syndrome.
Markusse HM; Breedveld FC; Fibbe WE
Arthritis Rheum; 1990 Dec; 33(12):1865-7. PubMed ID: 2261008
[No Abstract] [Full Text] [Related]
60. Economic and humanistic impact of adverse events associated with CSFs.
Gibson GA
Pharmacotherapy; 2000 Jul; 20(7 Pt 2):118S-120S. PubMed ID: 10905687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
